Skip to main content
. 2021 Dec 28;9:757826. doi: 10.3389/fchem.2021.757826

FIGURE 1.

FIGURE 1

Commonly repurposed drugs against SARS-CoV-2 with proposed direct action (ritonavir is mainly a pharmacokinetic modifier for its partner in combination therapy).